Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May 12;2(1):10.
doi: 10.1186/2040-7378-2-10.

EPO for stroke therapy - Is there a future for further clinical development?

Jens Minnerup  1 , Heike Wersching, Wolf-Rüdiger Schäbitz
Affiliations

EPO for stroke therapy - Is there a future for further clinical development?

Jens Minnerup et al. Exp Transl Stroke Med. .
No abstract available

PubMed Disclaimer

References

    1. Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, Schellinger PD, Bohn M, Becker H, Wegrzyn M. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke. 2009;40:e647–e656. doi: 10.1161/STROKEAHA.109.564872. - DOI - PubMed
    1. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med. 2002;8:495–505. - PMC - PubMed
    1. Minnerup J, Heidrich J, Rogalewski A, Schabitz WR, Wellmann J. The efficacy of erythropoietin and its analogues in animal stroke models: a meta-analysis. Stroke. 2009;40:3113–3120. doi: 10.1161/STROKEAHA.109.555789. - DOI - PubMed
    1. Philip M, Benatar M, Fisher M, Savitz SI. Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials. Stroke. 2009;40:577–581. doi: 10.1161/STROKEAHA.108.524330. - DOI - PubMed
    1. Crossley NA, Sena E, Goehler J, Horn J, van der WB, Bath PM, Macleod M, Dirnagl U. Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach. Stroke. 2008;39:929–934. doi: 10.1161/STROKEAHA.107.498725. - DOI - PubMed